Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Non Operating Income: 2019-2025

Historic Non Operating Income for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $1.0 million.

  • Benitec Biopharma's Non Operating Income rose 24.28% to $1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.8 million, marking a year-over-year increase of 420.70%. This contributed to the annual value of $3.8 million for FY2025, which is 420.70% up from last year.
  • According to the latest figures from Q2 2025, Benitec Biopharma's Non Operating Income is $1.0 million, which was up 23.38% from $834,000 recorded in Q1 2025.
  • Benitec Biopharma's 5-year Non Operating Income high stood at $1.3 million for Q4 2024, and its period low was -$513,000 during Q3 2022.
  • In the last 3 years, Benitec Biopharma's Non Operating Income had a median value of $430,500 in 2023 and averaged $442,000.
  • As far as peak fluctuations go, Benitec Biopharma's Non Operating Income crashed by 1,388.89% in 2021, and later spiked by 1,321.43% in 2022.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Non Operating Income stood at $14,000 in 2021, then skyrocketed by 1,321.43% to $199,000 in 2022, then plummeted by 35.18% to $129,000 in 2023, then skyrocketed by 871.32% to $1.3 million in 2024, then climbed by 24.28% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q2 2025, $834,000 for Q1 2025, and $1.3 million during Q4 2024.